Techno Trends

This section presents the latest developments, inventions, and revolutionary technologies that change the face of healthcare.

Breakthrough Device Designation for Diagnosis of Brain Tumors

A blood test called “TriNetra™-Glio” that aids in the detection of brain tumours has received "Breakthrough Device Designation" from the US Food and Drug Administration (FDA), according to a statement released by Datar Cancer Genetics. The US FDA has designated this test, the third from the company, as a breakthrough device. The first liquid biopsies to earn the Breakthrough Device Designation...

Opticyte Develops Breakthrough First Cell O2 Patient Monitor for Organ Failure

Opticyte has revolutionized patient monitoring with the introduction of the groundbreaking Cell O2 Patient Monitor. This innovative device has been granted breakthrough designation by the U.S. Food and Drug Administration (FDA)....

First-of-its-Kind Stretchable Strain Sensor Developed for Monitoring Health

The researchers at North Carolina State University have developed a stretchable strain sensor that has an unprecedented combination of sensitivity and range, allowing it to detect even minor changes in strain with a greater range of motion than previous technologies. The researchers developed new health monitoring and human-machine interaction devices to show...

Novel Radiation Treatment Developed to Treat Cancer Patients

A unique tracking radiation therapy has been developed by the University of Michigan researchers to treat cancer patients. When X-rays heat body tissues, the precise 3D imaging technology collects and amplifies minute sound waves. The radiation dose throughout the body can be mapped...

Novel Test Discovered for Multi-Cancer Detection

Burning Rock has developed OverC™, a cutting-edge method for multiple cancer screening through blood testing. The test is used to find many cancers in persons with average risk between the ages of 50 and 75, including esophagus, liver, lung, ovarian, and pancreatic cancers....

Sinaptica Therapeutics announces Phase 2 trial results for Alzheimer's Disease

According to phase 2 trial data published by Sinaptica Therapeutics, PC-rTMS, a precision-delivered noninvasive brain stimulation, delayed cognitive and functional deficits in those with mild-to-moderate dementia caused by Alzheimer's disease. 50 patients were included in a 24-week Phase II randomised, double-blind, sham-controlled...

CurveBeam AI's OssView™ Bone Fragility Software Developed

CurveBeam AI's OssViewTM, a pioneering bone frailty program, has been designated as a breakthrough product by the U.S. Food and Drug Administration (FDA). OssView introduces the concept of a Structural Fragility Score (SFS),...

Endostim's Breakthrough Device for Treatment of Drug Refractory GERD

Endostim has created a ground-breaking technology called the Endostim System, for the treatment of drug-resistant GERD. The new device was given Breakthrough Device Designation by the U.S. Food and Drug Administration (FDA). As a result of the device, medical device development, evaluation...

Philips Develops World’s First Spectral Detector Angio CT Solution

The Philips Spectral Angio CT suite, created by Royal Philips, is the first spectrum detector angio CT system in the world. It incorporates the company's revolutionary spectral CT imaging technology. In order to create a completely integrated interventional suite solution, Philips is creating...

Novel BP Monitoring Wearable Device Discovered

Livemetric discovered a novel nano-sensor for blood pressure called LiveOne. It provides readings every 10 seconds. The first MEMS nano-sensor, CE and FDA-cleared device in the world with medical accuracy correlated with arterial lines. LiveOne proposes the application of nanosensors to capture and process real-time blood pressure data....